Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Rotschafer

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
JAMA|February 7, 1986
The clinical utility of a published nomogram to predict aminoglycoside nephrotoxicityY W Lam, C J Arana, L R Shikuma, et al.
The Journal of Pediatrics|September 1, 1980
Vancomycin pharmacokineticsD Baker, J C Rotschafer, R Sawchuk, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1996
Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic modelK J Madaras-Kelly, B E Ostergaard, L B Hovde, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1982
Cefaclor pharmacokinetic parameters: serum concentrations determined by a new high-performance liquid chromatographic techniqueJ C Rotschafer, K B Crossley, T S Lesar, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2001
Fluoroquinolone resistance in anaerobic bacteria following exposure to levofloxacin, trovafloxacin, and sparfloxacin in an in vitro pharmacodynamic modelG H Ross, D H Wright, L B Hovde, et al.
Chemotherapy|March 1, 1997
Characterization of synergy between ofloxacin, ceftazidime, and tobramycin against Pseudomonas aeruginosaK J Madaras-Kelly, J Moody, A Larsson, et al.
Therapeutic Drug Monitoring|January 1, 1983
Observed differences in gentamicin pharmacokinetic parameters and dosage recommendations determined by fluorescent polarization immunoassay and radioimmunoassay methodsJ C Rotschafer, H G Berg, R B Nelson, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1980
Comparison of a radioimmunoassay and a microbiological assay for measurement of serum vancomycin concentrationsK B Crossley, J C Rotschafer, M M Chern, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1993
Elimination of quinolone antibiotic carryover through use of antibiotic-removal beadsR A Zabinski, A J Larsson, K J Walker, et al.
Therapeutic Drug Monitoring|February 1, 1994
Bayesian forecasting of serum vancomycin concentrations with non-steady-state sampling strategiesK A Rodvold, J C Rotschafer, S S Gilliland, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
JAMA|February 7, 1986
The clinical utility of a published nomogram to predict aminoglycoside nephrotoxicityY W Lam, C J Arana, L R Shikuma, et al.
The Journal of Pediatrics|September 1, 1980
Vancomycin pharmacokineticsD Baker, J C Rotschafer, R Sawchuk, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1996
Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic modelK J Madaras-Kelly, B E Ostergaard, L B Hovde, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1982
Cefaclor pharmacokinetic parameters: serum concentrations determined by a new high-performance liquid chromatographic techniqueJ C Rotschafer, K B Crossley, T S Lesar, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2001
Fluoroquinolone resistance in anaerobic bacteria following exposure to levofloxacin, trovafloxacin, and sparfloxacin in an in vitro pharmacodynamic modelG H Ross, D H Wright, L B Hovde, et al.
Chemotherapy|March 1, 1997
Characterization of synergy between ofloxacin, ceftazidime, and tobramycin against Pseudomonas aeruginosaK J Madaras-Kelly, J Moody, A Larsson, et al.
Therapeutic Drug Monitoring|January 1, 1983
Observed differences in gentamicin pharmacokinetic parameters and dosage recommendations determined by fluorescent polarization immunoassay and radioimmunoassay methodsJ C Rotschafer, H G Berg, R B Nelson, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1980
Comparison of a radioimmunoassay and a microbiological assay for measurement of serum vancomycin concentrationsK B Crossley, J C Rotschafer, M M Chern, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1993
Elimination of quinolone antibiotic carryover through use of antibiotic-removal beadsR A Zabinski, A J Larsson, K J Walker, et al.
Therapeutic Drug Monitoring|February 1, 1994
Bayesian forecasting of serum vancomycin concentrations with non-steady-state sampling strategiesK A Rodvold, J C Rotschafer, S S Gilliland, et al.
Pageof 9